### SDCBP2 Gene Overview

**General Information**: 
The SDCBP2 gene (Syndecan Binding Protein 2) encodes a protein with two class II PDZ domains. This protein is involved in mediating protein-protein interactions and is significant in cellular signaling and the assembly of protein complexes, particularly through its binding with the cytoplasmic C-termini of transmembrane proteins. It is also recognized for binding phosphatidylinositol 4,5-bisphosphate (PIP2) and has pivotal roles in nuclear PIP2 organization and cell division.

### 1. Associated Genes
While the specific summaries you provided primarily mention SDCBP2 and its association with FKBP1A, other genes that may be functionally related or associated with SDCBP2, based on existing literature, include:

- **PDZ domain-containing proteins**: Given the role of SDCBP2 containing PDZ domains, other PDZ domain proteins may be functionally linked.
- **Syndecan family genes (SDC)**: Given the contextual origin of the name, genes from the syndecan family might have interactions with SDCBP2.
- **Genes involved in phosphoinositide signaling**: Other genes related to cell signaling pathways mediated by PIP2 could be associated due to overlap in cellular functions.

### 2. Aging and Age-related Diseases
- **Cell Division and Tumorigenesis**: As SDCBP2 plays a role in cell division, aberrations in its function could potentially relate to age-associated diseases such as cancer. Dysregulation of cell signaling prompted by aging may influence SDCBP2 expression or function.
- **Developmental Disorders**: Variants or dysfunctions associated with SDCBP2 in signaling pathways can impact developmental processes that may be affected by age, although specific age-related conditions have not been extensively characterized.

### 3. Drug Interactions
Current literature does not point to highly specific drugs directly affecting SDCBP2. However, given its interaction with phosphoinositides, potential pharmacological agents that modulate lipid signaling pathways could influence SDCBP2 function. It’s advisable to research:

- **Phosphoinositide 3-kinase inhibitors**: As they may indirectly affect pathways involving PIP2.
- **Cancer therapeutics**: Given its role in cell proliferation, drugs targeting cell signaling pathways may have effects on SDCBP2-regulated processes.

### 4. Pathways and Biological Processes
SDCBP2 is involved in several key biological processes, including:

- **Cell Signaling**: Particularly through the modulation of PDZ domain-containing protein interactions and binding to PIP2.
- **Cell Division**: Its roles in organizing PIP2 suggest fundamental involvement in mitosis and cytokinesis.
- **Nuclear Organization**: Plays a part in the localization and function of nuclear PIP2, influencing nuclear signaling.

**Potential Pathways**:
- Phosphatidylinositol signaling pathways
- Protein-protein interaction pathways involving PDZ domain-containing proteins
- Signal transduction pathways that regulate cellular processes such as cytoskeletal organization and vesicle trafficking.

In summary, while further research is essential for elucidating the full implications of SDCBP2 in aging and therapeutic interactions, its known roles in signaling, cell division, and protein interaction networks highlight its potential importance in cellular function and pathology.